The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation

F. Meloni (Pavia, Italy), M. Morosini (Pavia, Italy), V. Codullo (Pavia, Italy), V. Frangipane (Pavia, Italy), S. Magni (Pavia, Italy), H. Recalde (Pavia, Italy), S. Inghilleri (Pavia, Italy), G. Comolli (Pavia, Italy), E. Cova (Pavia, Italy), C. Montecucco (Pavia, Italy), M. Colombo (Milan , Italy), D. Prosperi (Milan , Italy)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session: CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type: Poster Discussion
Number: 3660
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Meloni (Pavia, Italy), M. Morosini (Pavia, Italy), V. Codullo (Pavia, Italy), V. Frangipane (Pavia, Italy), S. Magni (Pavia, Italy), H. Recalde (Pavia, Italy), S. Inghilleri (Pavia, Italy), G. Comolli (Pavia, Italy), E. Cova (Pavia, Italy), C. Montecucco (Pavia, Italy), M. Colombo (Milan , Italy), D. Prosperi (Milan , Italy). The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation. 3660

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells
Source: ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018
Year: 2019



The inhibitory effect of fenretinide on the expression of inflammatory cytokines, possible molecular target of the drug and its relevance to cystic fibrosis.
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Designed core-shell nanoparticles: intracellular localization and pro-inflammatory cytokine release in lung cells
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009

Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017

Titanium dioxide nanoparticles induce IL-8 expression in lung epithelial cells by a MAPK-dependent mechanism
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Efficacy of imatinib loaded-antiCD44 coated gold nanoparticles: a possible new therapeutic approach to BOS
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Effect of surface functionalisation on the interaction of carbon nanotubes with primary human alveolar cells in vitro.
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017


Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of anti-fibrotic miR-142-3p
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Influence of heparin binding protein (HBP) on pro-inflammatory signal transduction and ICAM-1 expression in A549 cells
Source: Eur Respir J 2004; 24: Suppl. 48, 100s
Year: 2004

Pirfenidone induced inhibition of p38 downregulates procoagulant microparticle generation by human alveolar epithelia cells
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


The physicochemical properties of nanoparticles determine the mechanism of uptake by human alveolar type I epithelial cells
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010

Role of p53 in murine macrophages and alveolar epithelial cells response to nanoparticles
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011


Inhibitory effect of statins on fibrogenic mediator production from lung cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Pro-inflammtory effects of poorly soluble particles in human lung epithelial cells are dependent on surface area and surface reactivity
Source: Eur Respir J 2002; 20: Suppl. 38, 97s
Year: 2002

Selective inhibition of COX-2 by celecoxib exerts negative effects on endothelial progenitor cell proliferation and stimulates apoptosis in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005

Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008


Effect of TGFb on cytokine and costimulatory molecule expression by monocyte derived dendritic cells
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003


Enhanced endothelial barrier protective and anti-inflammatory effects by synthetic iloprost-conjugated phospholipid.
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018

Imatinib-loaded gold nanoparticles ameliorate experimental lung fibrosis induced by bleomycin
Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents
Year: 2017